We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adaptive Design Saves Time, Money But Use in Late Stage Trials Still Risky
Adaptive Design Saves Time, Money But Use in Late Stage Trials Still Risky
August 17, 2011
Adaptive design can save R&D time and money by allowing clinical researchers to terminate a trial early if the desired outcome appears unlikely, a new report says.